FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
ACETAMINOPHEN; CODEINE PHOSPHATE | 51655-802-53 | Northwind Pharmaceuticals, LLC | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 51655-802-54 | Northwind Pharmaceuticals, LLC | ANDA040779 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 51655-804-27 | Northwind Pharmaceuticals | ANDA201013 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-52 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-53 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-54 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
CODEINE PHOSPHATE; ACETAMINOPHEN | 51655-808-87 | Northwind Pharmaceuticals | ANDA202800 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 51655-898-20 | Northwind Pharmaceuticals, LLC | ANDA201013 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 51655-898-52 | Northwind Pharmaceuticals, LLC | ANDA201013 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 51655-898-53 | Northwind Pharmaceuticals, LLC | ANDA201013 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 51655-898-54 | Northwind Pharmaceuticals, LLC | ANDA201013 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 51655-899-20 | Northwind Pharmaceuticals | ANDA040655 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 51655-899-54 | Northwind Pharmaceuticals | ANDA040655 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; CODEINE PHOSPHATE | 51655-910-54 | Northwind Pharmaceuticals, LLC | ANDA211610 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN | 51660-333-01 | Ohm Laboratories Inc. | ANDA076200 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 51660-333-24 | Ohm Laboratories Inc. | ANDA076200 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 51660-333-50 | Ohm Laboratories Inc. | ANDA076200 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 51660-340-08 | Ohm Laboratories Inc. | ANDA078569 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 51660-340-20 | Ohm Laboratories Inc. | ANDA078569 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 51662-1274-2 | HF Acquisition Co LLC, DBA HealthFirst | 505G(a)(3) | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 51662-1424-1 | HF Acquisition Co LLC, DBA HealthFirst | NDA022450 | HUMAN PRESCRIPTION DRUG | NDA |
ACETAMINOPHEN | 51662-1540-2 | HF Acquisition Co LLC, DBA HealthFirst | ANDA210969 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN | 51662-1540-3 | HF Acquisition Co LLC, DBA HealthFirst | ANDA210969 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN | 51672-2114-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2114-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2114-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2115-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2115-2 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2115-4 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
ACETAMINOPHEN | 51672-2116-0 | Taro Pharmaceuticals U.S.A. Inc. | NDA018337 | HUMAN OTC DRUG | NDA |
-